Klein, E. W.; Williams, S. F.
July 1962
American Journal of Gastroenterology;Jul1962, Vol. 38 Issue 1, p69
Academic Journal
Provides information on gastric carcinoma in young adults. Factor which has been responsible for the tendency to overlook the diagnosis of malignancy when the patient is 30 years of age, or younger; Probable diagnosis of gastric carcinoma; Details of a case report on carcinoma of the stomach of a 22-year old Negro male.


Related Articles

  • IL-33 Promotes Gastric Cancer Cell Invasion and Migration Via ST2-ERK1/2 Pathway. Yu, Xi-Xiang; Hu, Zhe; Shen, Xian; Dong, Li-Yang; Zhou, Wei-Zhong; Hu, Wen-Hao // Digestive Diseases & Sciences;May2015, Vol. 60 Issue 5, p1265 

    Background: As a pro-inflammatory cytokine, IL-33 has been demonstrated to play an important role in tumor progression. It is reported that IL-33 is highly expressed in the serum and tumor tissues of patients with gastric cancer. However, the function of IL-33 in gastric cancer remains elusive....

  • Monitoring Cortical Excitability during Repetitive Transcranial Magnetic Stimulation in Children with ADHD: A Single-Blind, Sham-Controlled TMS-EEG Study. Helfrich, Christian; Pierau, Simone S.; Freitag, Christine M.; Roeper, Jochen; Ziemann, Ulf; Bender, Stephan // PLoS ONE;Nov2012, Vol. 7 Issue 11, Special section p1 

    Background: Repetitive transcranial magnetic stimulation (rTMS) allows non-invasive stimulation of the human brain. However, no suitable marker has yet been established to monitor the immediate rTMS effects on cortical areas in children. Objective: TMS-evoked EEG potentials (TEPs) could present...

  • Estimation of an Optimal Chemotherapy Utilisation Rate for Upper Gastrointestinal Cancers: Setting an Evidence-Based Benchmark for the Best-Quality Cancer Care. Ng, Weng; Jacob, Susannah; Delaney, Geoff; Do, Viet; Barton, Michael // Gastroenterology Research & Practice;3/26/2015, Vol. 2015, p1 

    Aims. The proportion of patients with upper gastrointestinal cancers that received chemotherapy varies widely in Australia and internationally, indicating a need for a benchmark rate of chemotherapy utilisation. We developed evidence-based models for upper gastrointestinal cancers to estimate...

  • Gastric Sarcomatoid Carcinoma. Carboni, Fabio; Levi Sandri, Giovanni; Valle, Mario; Covello, Renato; Garofalo, Alfredo // Journal of Gastrointestinal Surgery;Nov2013, Vol. 17 Issue 11, p2025 

    Sarcomatoid carcinoma is an uncommon biphasic malignant tumor of the stomach. The histogenesis remains unknown, and a definitive diagnosis is obtained with immunohistochemical staining. Since prognosis is poor after surgery, more effective diagnostic tools are needed in order to select the...

  • No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapy. Bernards, N.; Creemers, G. J.; Nieuwenhuijzen, G. A. P.; Bosscha, K.; Pruijt, J. F. M.; Lemmens, V. E. P. P. // Annals of Oncology;Dec2013, Vol. 24 Issue 12, p3056 

    Background Gastric cancer often presents in a metastasized stage. We conducted a population-based study to evaluate trends in systemic treatment and survival of metastatic noncardia gastric cancer. Patients and methods All patients with noncardia adenocarcinoma of the stomach, diagnosed between...

  • Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer. Qu, Jing-lei; Qu, Xiu-juan; Li, Zhi; Zhang, Jing-dong; Liu, Jing; Teng, Yue-e; Jin, Bo; Zhao, Ming-fang; Yu, Ping; Shi, Jing; Fu, Ling-yu; Wang, Zhen-ning; Liu, Yun-peng // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Prognostic models are generally used to predict gastric cancer outcomes. However, no model combining patient-, tumor- and host-related factors has been established to predict outcomes after radical gastrectomy, especially outcomes of patients without nodal involvement. The aim of this study was...

  • Diversity of Clinical Implication of B-Cell Translocation Gene 1 Expression by Histopathologic and Anatomic Subtypes of Gastric Cancer. Kanda, Mitsuro; Oya, Hisaharu; Nomoto, Shuji; Takami, Hideki; Shimizu, Dai; Hashimoto, Ryoji; Sueoka, Satoshi; Kobayashi, Daisuke; Tanaka, Chie; Yamada, Suguru; Fujii, Tsutomu; Nakayama, Goro; Sugimoto, Hiroyuki; Koike, Masahiko; Fujiwara, Michitaka; Kodera, Yasuhiro // Digestive Diseases & Sciences;May2015, Vol. 60 Issue 5, p1256 

    Background: Genetic signatures may differ by histopathologic and anatomic subtypes of gastric cancer (GC). B-cell translocation gene 1 ( BTG1) was identified as one of genes downregulated in GC tissues from our microarray data. Aims: To evaluate the clinical implications of BTG1 expression in GC...

  • A tumor marker panel scoring system to improve clinical stage in gastric cancer. Jun Gong; Jiu-Yang Liu; Chun-Wei Peng; Yang Yu; Xiao-Hua Leng; Cong-Hua Xie; Yan Li // International Journal of Clinical & Experimental Medicine;2016, Vol. 9 Issue 7, p14304 

    Objective: To investigate the correlation among tumor markers test/reference cutoff ratio score (TRRS), disease progression and clinical stages in gastric cancer (GC). Methods: 708 patients hospitalized because of GC for the first time with preoperative tumor makers [carcinoembryonic antigen...

  • A mixed adenoneuroendocrine carcinoma of the pancreas: a case report. Imaoka, Kouki; Fukuda, Saburo; Tazawa, Hirofumi; Kuga, Yoshio; Mochizuki, Tetsuya; Hirata, Yuzo; Fujisaki, Seiji; Takahashi, Mamoru; Nishida, Toshihiro; Sakimoto, Hideto // Surgical Case Reports;11/15/2016, Vol. 2 Issue 1, p1 

    A tumor consisting of an adenocarcinoma component and a neuroendocrine carcinoma component, with each component accounting for at least 30% of the tumor, is defined as a mixed adenoneuroendocrine carcinoma (MANEC). We report a case of MANEC of the pancreas. A 63-year-old man presented with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics